Stock Events

Stock Events

Sanofi

C$21.73

5341

-C$0.22-1%Friday 20:55

Statistics

Day High

21.73

Day Low

21.73

52W High

22.57

52W Low

18.13

Volume

300

Avg. Volume

-

Mkt Cap

52.07B

P/E Ratio

3.66

Dividend Yield

3.69%

Dividend

0.8

Upcoming

Dividend Payment

Dividend Payment

Dividends

3.69%Dividend Yield

May 2026

C$0.80

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

Jul 30Expected

Q4 2025

Q2 2026

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

Financials

17.32%Profit Margin

Profitable

2020

2021

2022

2023

2024

2025

73.15BRevenue

12.67BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNY.TO. It's not an investment recommendation.

Lvmh Moet Hennessy Louis Vuitton

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer competes directly with Sanofi in various therapeutic areas, including vaccines and oncology.

Merck is a key competitor in the pharmaceutical sector, especially in vaccines and immunology, areas where Sanofi also operates.

Novartis competes with Sanofi in multiple segments including generics through Sandoz, and in innovative prescription drugs.

Johnson & Johnson

Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals in areas overlapping with Sanofi's portfolio.

GlaxoSmithKline is a competitor in the vaccines and respiratory diseases market, directly competing with Sanofi.

AbbVie competes in the immunology and oncology sectors, directly challenging Sanofi's offerings.

Roche, through its pharmaceutical division, competes in the oncology and immunology markets, areas where Sanofi is also a key player.

AstraZeneca competes with Sanofi in areas such as oncology, cardiovascular diseases, and respiratory diseases.

Bristol-Myers Squibb

Bristol Myers Squibb competes in the oncology, cardiovascular, and immunoscience fields, overlapping with Sanofi's interests.

Amgen competes in the biopharmaceutical sector focusing on treatments in areas like oncology and osteoporosis, where Sanofi also has a presence.

About

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Show More

CEO

Belén Garijo López

Employees

74846

Country

France

ISIN

CA8010MA1047

WKN

000A41T8R

Listings

0 Comments

Share your thoughts

FAQs

What is Sanofi stock price today?▼

The current price of SNY.TO is C$21.73 CAD — it has decreased by -1% in the past 24 hours. Watch Sanofi stock price performance more closely on the chart.

What is Sanofi stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Toronto Exchange exchange Sanofi stocks are traded under the ticker SNY.TO.

What is Sanofi market cap?▼

Today Sanofi has the market capitalization of 52.07B

What is Sanofi revenue for the last year?▼

Sanofi revenue for the last year amounts to 73.15B CAD.

What is Sanofi net income for the last year?▼

SNY.TO net income for the last year is 12.67B CAD.

Does Sanofi pay dividends?▼

Yes, SNY.TO dividends are paid annual. The last dividend per share was 0.8 . As of today, Dividend Yield (FWD)% is 3.69%.

How many employees does Sanofi have?▼

As of November 7, 2026, the company has 74,846 employees.

In which sector is Sanofi located?▼

Sanofi operates in the Health & Wellness sector.

When did Sanofi complete a stock split?▼

Sanofi has not had any recent stock splits.

Where is Sanofi headquartered?▼

Sanofi is headquartered in Paris, France.